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1. 
NORGANICNANOWIRES 
This application is a Continuation of U.S. application Ser. 
No. 13/041,236, filed Mar. 4, 2011, now U.S. Pat. No. 8,201, 
724, which is a Continuation of U.S. application Ser. No. 5 
10/976,179. filed Oct. 29, 2004, now U.S. Pat. No. 7,923,109, 
which claims benefit under 35 U.S.C. 119(e) to U.S. Provi 
sional Application No. 60/534,102, filed Jan. 5, 2004, which 
are hereby incorporated by reference in their entirety. 
This invention was made with government Support 10 
awarded by the Army Research Office under Grant Number 
DAAD 19-03-1-0088. The government has certain rights in 
the invention. 
INTRODUCTION 15 
The reliance of a wide variety of technologies on develop 
ing scalable and economic methods for the fabrication of 
one-dimensional materials, including nanowires and nano 
tubes, has spurred intense and rapid progress in the area of 20 
materials synthesis. For example, one-dimensional materials 
have been enthusiastically pursued for their applications in 
the study of for example, electrical transport (1), optical 
phenomena (2), and as functional units in nanocircuitry (3). 
Pursuit of “bottom up' methods for the synthesis of semicon- 25 
ducting, metallic and magnetic nanowires has yielded a vari 
ety of synthetic strategies including, but not limited to, Vapor 
Liquid Solid (VLS) (4), chemical (5), solvothermal, vapor 
phase, and template-directed fabrication (6). Although each 
method developed for the production of nanowires has had 30 
Some basic Success in achieving high quality materials, meth 
ods to date have not yielded monodisperse, crystalline 
nanowires of radically different compositions. In general, 
prior methods for nanowire production can be erratic, Syn 
thetically cumbersome, and are not universal. See, for 35 
example, U.S. Pat. No. 6.225, 198 to Alivisatos et al. for II-VI 
semiconductor production in liquid media and references 
cited herein. Reference 4 to Lieber et al. describes the diffi 
culty in finding a universal approach. It describes a VLS 
process that requires use of lasers and high temperatures and 40 
produces a nanowire having a nanoparticle at the end which 
may not be desirable. 
Recently, biological factors have been exploited as synthe 
sis directors for nanofibers (7.8), virus-based particle cages 
(9), virus-particle assemblies (10, 11, 12), and non-specific 45 
peptide templates (13). This is due to the high degree of 
organization, ease of chemical modification and naturally 
occurring self-assembly motifs in these systems. 
Belcher et al. have prepared nanowires associated with and 
bound to genetically engineered viral scaffolds (see, for 50 
example, U.S. Patent Publication, 2003/0068900 to Belcher 
et al.). The scaffolds serve as a template as nanoparticles or 
nanocrystals form on the scaffold. Although this technology 
is attractive and provides important advantages, a need exists 
to improve upon it. For example, it is desirable to generate 55 
improved properties such as improved fusion between the 
nanocrystals and reduction in defects. It is also desirable to 
fuse the nanocrystals into one long single crystal rod or into 
large crystalline domains. Moreover, it is desirable in many 
applications to not have and Substantially eliminate the viral 60 
scaffold bound to or associated with the viral scaffold. More 
over, it is desirable to control the size and size statistical 
distributions for the nanowires including, for example, pre 
pare monodisperse materials and materials having controlled 
length. If possible, the nanowires should be usable directly, 65 
without need for a size-based separation step before use. A 
need also exists to be able to connect the nanowires with other 
2 
components such as electrodes which allow the nanowires to 
be commercially useful. These connections should, if pos 
sible, not be mere chance connections but be strategically 
directed and controllable. 
References numerically cited in this specification are pro 
vided in a listing at the end of the specification and are 
incorporated by reference in the specification in their entirety. 
SUMMARY 
The present invention in many of its embodiments is Sum 
marized in this non-limiting Summary section. 
In one embodiment, the present invention provides an inor 
ganic nanowire having an organic scaffold Substantially 
removed from the inorganic nanowire, the inorganic nanow 
ire consisting essentially of fused inorganic nanoparticles 
substantially free of the organic scaffold (“the inorganic 
nanowire of embodiment 1). 
The present invention also provides compositions and 
devices comprising a plurality of these inorganic nanowires. 
In another embodiment, the present invention provides a 
composition comprising a plurality of inorganic nanowires, 
wherein the inorganic nanowires comprise fused inorganic 
nanoparticles Substantially free of organic scaffold. 
In another embodiment, the present invention provides a 
method of forming an inorganic nanowire comprising the 
steps of: (1) providing one or more precursor materials for the 
inorganic nanowire; (2) providing an elongated organic scaf 
fold; (3) reacting the one or more precursor materials in the 
presence of the scaffold to form nanoparticles, wherein the 
nanoparticles are disposed along the length of the elongated 
organic scaffold; and (4) thermally treating the scaffold and 
the nanoparticles to form the inorganic nanowire by fusion of 
the nanoparticles. In some embodiments, the organic scaffold 
can be removed. Such as during the thermal treatment. The 
present invention also provides nanowires prepared by this 
method. 
Also provided is a method of forming an inorganic nanow 
ire comprising the steps of: (1) providing one or more pre 
cursor materials for the inorganic nanowire; (2) providing an 
organic scaffold; (3) reacting the one or more precursor mate 
rials in the presence of the scaffold under conditions to form 
the inorganic nanowire. In some embodiments, the organic 
scaffold can be removed, such as during the reacting. The 
present invention also provides nanowires prepared by this 
method. 
The present invention also provides for use of a filamentous 
organic scaffold as a sacrificial organic scaffold in the pro 
duction of an inorganic nanowire comprising providing a 
filamentous organic scaffold and an inorganic nanowire pre 
cursor on the scaffold, converting the inorganic nanowire 
precursor to the inorganic nanowire while removing the fila 
mentous organic scaffold to yield the inorganic nanowire. 
An additional use provided herein is the use of an elongated 
organic scaffold to control the length of an inorganic nanow 
ire disposed thereon, comprising the step of genetically engi 
neering the scaffold to control the length of the scaffold. 
An important embodiment is also a device comprising an 
electrode in electrical contact with the inorganic nanowire of 
embodiment 1 or any other nanowire described herein. In 
another embodiment, the device can further comprise at least 
two electrodes each in electrical contact with the inorganic 
nanowire of embodiment 1 or any other nanowire described 
herein. Examples of devices include a field effect transistor or 
a sensor. In other embodiments, the device comprises at least 
two nanowires according to embodiment 1, or any other 
US 8,523,044 B2 
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nanowires described herein, wherein the nanowires are in a 
parallel arrangement, or in a crossed arrangement. 
The invention also provides a segmented nanowire com 
prising a plurality of connected segments of inorganic nanow 
ires of embodiment 1 or any other nanowires described 
herein. In some embodiments, the scaffold was used to form 
the nanowire and/or direct the placement of the nanowire 
before being removed. 
The invention also provides a composition comprising a 
plurality of inorganic nanowires, wherein the inorganic 
nanowires comprise fused inorganic nanoparticles that were 
disposed on an organic scaffold. In some embodiments, the 
scaffold(s) were used to form the nanowires and/or direct the 
placement of the nanowires, such as placement in a circuit 
substrate, before being removed. 
The invention also provides a process for producing 
nanowires with use of an elongated organic scaffold compris 
ing the steps of: (1) providing an elongated organic scaffold 
which comprises a plurality of binding sites including bind 
ing sites along the length of the scaffold and binding sites on 
at least one end of the scaffold; (2) disposing a nanowire 
precursor composition along the length of the scaffold to form 
a scaffolded precursor composition; and (3) treating the scaf 
folded precursor composition to form the nanowire. In some 
embodiments, the scaffold is Substantially removed. Such as 
during the treating step. In one embodiment, the elongated 
organic scaffold has binding sites at both ends of the scaffold. 
In another embodiment, the process further comprises the 
step of using the binding site at the end of the scaffold to bind 
to another structure. For example, the another structure can be 
another elongated organic scaffold. 
The invention also provides compositions. For example, in 
one embodiment, a nanowire composition is provided com 
prising a nanowire with a thermodynamically high energy 
phase, or a collection of nanowires according to this embodi 
ment, wherein the nanowires are Substantially monodisperse 
in length, width, or length and width. In this embodiment, the 
nanowire can be an inorganic nanowire Such as, for example, 
a nanowire of semiconductive material, metallic material, 
metal oxide material, magnetic material, or mixtures thereof. 
The invention also provides an inorganic nanowire com 
prising fused inorganic nanoparticles, or a composition com 
prising a collection of inorganic nanowires according to this 
embodiment. In this embodiment, the invention also provides 
an inorganic nanowire comprising fused inorganic nanopar 
ticles comprising semiconductor material, metallic material, 
metal oxide material, or magnetic material, as well as collec 
tions of these nanowires. 
The invention also provides an inorganic nanowire consist 
ing essentially of fused inorganic nanoparticles that were 
disposed on an organic scaffold. 
A basic and novel feature for many embodiments of the 
present invention is the Substantial elimination of the organic 
scaffold when it is used to prepare the nanowire. In many 
embodiments, its preferred that the organic scaffold be totally 
eliminated. Moreover, a basic and novel advantage in many 
embodiments is that the nanowires can be fabricated directly 
with good monodispersity without use of a size-based sepa 
ration of some nanowires from other nanowires. 
BRIEF DESCRIPTION OF DRAWINGS 
FIGS. 1A-D illustrate viruses which can be used as scaf 
folds. 


















The present invention provides, in one embodiment, an 
inorganic nanowire having an organic scaffold Substantially 
removed from the inorganic nanowire, the inorganic nanow 
ire consisting essentially of fused inorganic nanoparticles 
substantially free of the organic scaffold. The present inven 
tion also provides compositions comprising a plurality of 
these inorganic nanowires. This invention also provides com 
positions comprising a plurality of inorganic nanowires, 
wherein the inorganic nanowires comprise fused inorganic 
nanoparticles Substantially free of organic scaffold. 
The organic scaffold is generally removed so that, prefer 
ably, it cannot be detected on the nanowire. This substantial 
removal can be described in terms of weight percentage 
remaining. For example, the amount of remaining organic 
scaffold with respect to the total amount of nanowire and 
scaffold can be less than 1 wt.%, more preferably, less than 
0.5 wt.%, and more preferably, less than 0.1 wt.%. A basic 
and novel feature of the invention is the substantial removal of 
the scaffold in the production of high quality nanowires. 
In another patent application, which is hereby incorporated 
by reference in its entirety, U.S. Ser. No. 10/665,721 filed 
Sep. 22, 2003 to Belcher et al. (“Peptide Mediated Synthesis 
of Metallic and Magnetic Materials”), additional description 
is provided for burning off and elimination of a viral scaffold 
from materials to which the scaffold can selectively bind. In 
this application, annealing temperatures of 500-1,000° C. are 
described for burning off the scaffold. In addition, Mao et al., 
Virus-based toolkit for the directed synthesis of magnetic and 
semiconducting nanowires, Science 303:213-217 (2004), 
which is hereby incorporated by reference including all fig 
ures and the experimental section, includes some teachings 
that may be useful in practicing the present invention. Fairley, 
Peter, (2003) Germs That Build Circuits, IEEE Spectrum 
37-41, which is hereby incorporated by reference in its 
entirety including all figures and use of electrodes connected 
by nanowires, also includes teachings that may be useful in 
practicing the present invention, Such as applications of 
nanowires. Priority provisional application No. 60/534,102 
filed Jan. 5, 2004 by Belcher et al., is hereby incorporated by 
reference in its entirety. 
The detailed description of the invention is organized 
according to the following sections: (1) introduction, (2) scaf 
fold which is substantially removed, (3) nanowires, (4) meth 
ods of making nanowires, (5) applications for the nanowires, 
and (6) working examples. 
II. Scaffold 
Although the scaffold ultimately may be substantially 
removed from the nanowire, the scaffold is an important part 
of the invention. In the practice of the present invention, one 
skilled in the art can refer to technical literature for guidance 
on how to design and synthesize the scaffold including the 
literature cited herein and listed at the conclusion of the 
specification. For example, although the present invention 
relates to organic scaffolds and is not limited only to viral 
scaffolds in its broadest scope, viral scaffolds are a preferred 
embodiment. In particular, an elongated organic scaffold can 
be used which is a virus, and the term virus can include both 
a full virus and a virus subunit such as a capsid. The literature 
describes the preparation of viral scaffolds through genetic 
engineering with recognition properties for exploitation in 
materials synthesis. This includes use of viruses in the pro 
US 8,523,044 B2 
5 
duction of inorganic materials which have technologically 
useful properties and nanoscopic dimensions. In the present 
invention, one skilled in the art can use the literature in the 
practice of the present invention to prepare inorganic nanow 
ires on scaffolds, wherein the scaffolds are later substantially 
eliminated so that the inorganic nanowire is substantially free 
of the scaffold. When the scaffold is intended to be removed, 
the scaffold may be referred to as a “sacrificial scaffold.” 
One skilled in the art, for example, can refer to the follow 
ing patent literature for selection of the virus, genetic engi 
neering methods, and for materials to be used with genetically 
engineered viruses. Phage display libraries and experimental 
methods for using them in biopanning are further described, 
for example, in the following U.S. patent publications to 
Belcher et al.: (1) “Biological Control of Nanoparticle Nucle 
ation, Shape, and Crystal Phase': 2003/0068900 published 
Apr. 10, 2003; (2) “Nanoscale Ordering of Hybrid Materials 
Using Genetically Engineered Mesoscale Virus’: 2003/ 
0073104 published Apr. 17, 2003; (3) “Biological Control of 
Nanoparticles': 2003/01 13714 published Jun. 19, 2003; and 
(4) “Molecular Recognition of Materials’: 2003/0148380 
published Aug. 7, 2003, which are each hereby incorporated 
by reference in their entirety. Additional patent applications 
useful for one skilled in the art describe viral and peptide 
recognition studies with use of genetically engineered viruses 
for materials synthesis and applications including, for 
example, (1) U.S. Ser. No. 10/654,623 filed Sep. 4, 2003 to 
Belcher et al. (“Compositions, Methods, and Use of Bi-Func 
tional BioMaterials”), (2) U.S. Ser. No. 10/665,721 filed Sep. 
22, 2003 to Belcher et al. (“Peptide Mediated Synthesis of 
Metallic and Magnetic Materials”), and (3) U.S. Ser. No. 
10/668,600 filed Sep. 24, 2003 to Belcher et al. (“Fabricated 
BioFilm Storage Device'), (4) U.S. provisional Ser. No. 
60/510,862 filed Oct. 15, 2003 and the U.S. utility application 
Ser. No. 10/965,665 filed Oct. 15, 2004 to Belcher et al. 
(“Viral Fibers’); and (5) U.S. provisional Ser. No. 60/51 1,102 
filed Oct. 15, 2003 and the U.S. utility application Ser. No. 
10/965,227 filed Oct. 15, 2004 to Belcher et al. (Multifunc 
tional Biomaterials...'); each of which are hereby incorpo 
rated by reference. These references describe a variety of 
specific binding modifications which can be carried out for 
binding to conjugate structures, as well as forming the con 
jugate structures in the presence of the material modified for 
specific binding. In particular, polypeptide and amino acid 
oligomeric sequences can be expressed on the Surfaces of 
viral particles, including both at the ends and along the length 
of the elongated virus particle Such as M13 bacteriophage, 
including plII and pVIII expressions, as well as pix, pVII, 
and pVI expressions, and combinations thereof. Using these 
expression sights, the viruses may be engineered to express 
Surface peptides along the length of the virus, at the ends of 
the virus, or any number of other sites and combinations of 
sites. A single site for modification can be modified with more 
than one unit for specific binding. For example, a pVIII site 
can be modified to have two distinctly different binding units. 
In addition, different sites for modification can be modified 
with the same or different units for binding. For example, the 
ends of the virus particles can be modified to bind to specifi 
cally binda first material, while the body of the virus particles 
can be modified to bind a second material. Multiple binding 
sites can be used to create multifunctional scaffolds that can 
be used to form nanowires with specifically engineered and 
varying compositions among other applications. The binding 
sites can be designed so that nanoparticles nucleate at the 
binding sites or the binding sites can be designed to bind 













with sufficient binding units to achieve the desired concen 
tration needed to form the nanowire. 
In addition, the paper “Selection of Peptides with Semi 
conductor Binding Specificity for Directed Nanocrystal 
Assembly’; Whaley et al., Nature, Vol. 405, Jun. 8, 2000, 
pages 665-668, herein incorporated by reference, describes a 
method of selecting peptides with binding specificity using a 
combinatorial library. Specifically, the article shows a method 
of selecting peptides with binding specificity to semiconduc 
tor materials using a combinatorial library with about 10 
different peptides. The combinatorial library of random pep 
tides, each containing 12 amino acids, were fused to the pII 
coat protein of M13 coliphage and exposed to crystalline 
semiconductor structures. Peptides that bound to the semi 
conductor materials were eluted, amplified, and re-exposed to 
the semiconductor materials under more stringent conditions. 
After the fifth round of selection, the semiconductor specific 
phages were isolated and sequenced to determine the binding 
peptide. In this manner, peptides were selected with high 
binding specificity depending on the crystallographic struc 
ture and composition of the semiconductor material. The 
technique can be modified to obtain peptides with a binding 
specificity for not just semiconductor materials, but a range of 
both organic and inorganic materials. 
One skilled in the art can also refer to, for example, C. E. 
Flynn et al. Acta Materialia, vol 13, 2413-2421 (2003) 
entitled "Viruses as vehicles for growth, organization, and 
assembly of materials.” This reference, as well as all refer 
ences cited therein, are incorporated herein by reference in 
their entirety. In addition, reference 12 below (Mao et al., 
PNAS) is hereby incorporated by reference for all of its 
teachings including the nucleation and structures shown in 
FIG.1. Also, in particular, reference 17 (Flynn et al., J. Mater. 
Chem) is also incorporated by reference in its entirety includ 
ing descriptions of using aqueous salt compositions to nucle 
ate nanocrystals which are directed in their crystal structure 
and orientation by the recognition sites. In the present inven 
tion, these nucleated nanocrystals can be converted to single 
crystalline and polycrystalline nanowires, wherein the scaf 
fold is substantially removed. 
The scaffold is further described including the role of 
genetic programming for the preferred embodiments. 
Although the viral scaffolds represent a preferred embodi 
ment, the present invention comprises other types of non-viral 
scaffolds as well. Also, although M13 virus is a preferred 
embodiment for a scaffold, the present invention is not lim 
ited to this virus. 
The scaffold can comprise an entire virus, a virion, or viral 
Subunits including capsids. Viral Subunits including proteins, 
peptides, nucleic acids, DNA, RNA, and the like, in various 
combinations. The scaffold does not require that both peptide 
and nucleic acid be present. For example, virus mimics can be 
used or engineered, wherein the size, shape, or structure 
mimics that of a virus, but the does not contain nucleic acid 
and/or may not have the ability to infect a host for replication. 
One skilled in the art can prepare viral scaffolds based on 
purely synthetic methods from the bottom up as well as using 
more traditional methods wherein materials are supplied by 
nature without or without modification by man. 
In a preferred embodiment, wherein the scaffold is a virus 
or a virus subunit, the scaffold is tailored and designed in 
structure and function by genetic programming and/or 
genetic engineering for production of the one dimensional 
materials such as nanowires. The genetic programming can 
be used to tailor the scaffold for the particular application, and 
applications are described further below. The references in 
Section I describe genetic programming which is further 
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described in this section for use in practice of the present 
invention. See, e.g., Genetically Engineered Viruses, Chris 
topher Ring and E. D. Blair (Eds.), Bios Scientific, 2001, for 
descriptions of developments and applications in use of 
viruses as vehicles and expressors of genetic material includ 
ing, for example, prokaryotic viruses, insect viruses, plant 
viruses, animal DNA viruses, and animal RNA viruses. In the 
present invention, genetic programming can be carried out to 
engineer a scaffold using the different displayed peptide fea 
tures of a virus such as, for example, a filamentous bacte 
riophage such as, for example, the M13 virus which has a rod 
shape. Genetic programming can be used to control the scaf 
fold for materials synthesis, the viral scaffold comprising one 
or more viral particle subunits which may or may not include 
the nucleic acid subunit of the virus. Also, the scaffold may or 
may not retain infectability. 
An overall commercial advantage to this genetic program 
ming approach to materials engineering, in addition to mate 
rials-specific addressability, is the potential to specify viral 
length and geometry. For example, an elongated organic scaf 
fold may be genetically engineered to control the length of the 
scaffold. This engineering of length can allow the design of 
nanowires of specific, controlled lengths, for example. 
Hence, a variety of methods can be used to control the scaf 
fold length and geometry. 
For example, the length of a filamentous virus is generally 
related to the size of its packaged genetic information and the 
electrostatic balance between the pVIII-derived core of the 
virion and the DNA. See, e.g., B. K. Kay, J. Winter, J. McCaf 
ferty, Phage Display of Peptides and Proteins: A Laboratory 
Manual, Academic Press, San Diego, 1996; Greenwood et al., 
Journal of Molecular Biology 217:223-227 (1992). Phage 
observed by AFM generally are seen to be roughly 860 nm 
and as short as 560 nm depending on whether the complete 
M13 genome or Smaller phagemid are used in sample prepa 
ration. See, e.g., reference 12, C. Mao, C. E. Flynn, A. Hay 
hurst, R. Sweeney, J. Qi, J. Williams, G. Georgiou, B. Iverson, 
A. M. Belcher, Proc. Natl. Acad. Sci. 2003, 100, 6946. Also, 
changing a single lysine to glutamine on the inner-end of 
pVIII can result in particles approximately 35% longer than 
wild type phage. See, e.g., J. Greenwood, G. J. Hunter, R. N. 
Perham, J. Mol. Biol. 1991, 217, 223. 
In addition, specific linkage, binding, and concatenation of 
virus particles can help produce longer viral scaffolds, and 
thus longer nanowires. The multiplicity of additions can be 
controlled by engineering binding motifs into one virus, 
which then can accurately recognize binding sites on another 
virus. For example, the plII protein resides at one end of the 
M13 virus and can be exploited to display peptide and protein 
fusions. At the other end of the virus, the plX and pVII 
proteins also can be subject to modification. For example, 
Gao and coworkers utilized pX and pVII fusions to display 
antibody heavy- and light-chain variable regions. See, e.g., 
C. Gao, S. Mao, G. Kaufmann, P. Wirsching, R. A. Lerner, K. 
D. Janda, Proc. Natl. Acad. Sci. 2002, 99, 12612 See, also, 
for example, U.S. Pat. No. 6,472,147 for genetic modification 
of viruses. These end modifications may be used to link the 
virus particles directly or the end modifications may specifi 
cally bind to a linker. The linker may be any suitable material. 
For example, the linker can be a nanoparticle, amino acid 
oligomer, nucleic acid oligomer, or a polymer. This present 
invention encompasses dual-end viral display, either forgen 
erating bimodal heterostructures, or in combination with 
pVIII, producing end-functionalized nanowires. 
In addition, dual-end directional linkages enable creation 
of other interesting and commercially useful geometries, 














end of a virus directly to the other end of the virus without the 
use of a linker can be used to form rings, wires, or other viral 
based structures as well. By engineering recognition sites and 
the corresponding conjugate moieties into a single virus, or 
multiple viruses, the entire system can be genetically pro 
grammed. 
An important advantage of the invention is that the organic 
scaffold can be an active scaffold, wherein the scaffold not 
only serves as a template for synthesis of the inorganic 
nanowire, but also actively assists in coupling the inorganic 
nanowire to other structures. For example, an organic scaffold 
which is designed at one end to bind to another structure can 
be used to couple the inorganic nanowire to the structure. The 
scaffolds and the nanowires can be coupled to each other, for 
example, to form segments of similar or dissimilar materials. 
In this embodiment, the composition of the nanowire would 
vary as a function of length. 
Additional description is provided for the types of viral 
structures which can be designed by genetic programming for 
particular applications based on length control, geometry 
control, binding control, and the like. The virus scaffold is not 
particularly limited, and combinations of viruses can be used 
of different types. In general, viruses can be used which can 
be multifunctionalized. In general, virus particles which are 
long, filamentous structures can be used. See, e.g., Geneti 
cally Engineered Viruses, Christopher Ring (Ed.), Bios Sci 
entific, 2001, pages 11-21. Additionally, other viral geom 
etries such as dodecahedral and icosahedral can be 
multifunctionalized and used to create composite materials. 
Virus particles which can function as flexible rods, forming 
liquid crystalline and otherwise aligned structures, can be 
used. 
In particular, phage display libraries, directed evolution, 
and biopanning are an important part of genetic programming 
of viruses, and viruses can be used which have been subjected 
to biopanning in the viral design so that the virus particles 
specifically can recognize and bind to materials which were 
the object of the biopanning. The materials can also be nucle 
ated and synthesized in particulate form, including nanopar 
ticulate form, in the presence of the specific recognition and 
binding sites. Use of filamentous virus in so called directed 
evolution or biopanning is further described in the patent 
literature including, for example, U.S. Pat. Nos. 5.223,409 
and 5,571,698 to Ladner et al. (“Directed Evolution of Novel 
Binding Proteins'). Additional references on the recognition 
properties of viruses include U.S. Pat. No. 5,403.484 (phage 
display libraries, now commercially available) and WO 
O3/O784.51. 
Mixtures of two or more different kinds of viruses can be 
used. Mixtures of virus particles with non-virus materials can 
be used informing materials which use the present invention. 
Virus and virus particle can include both an entire virus and 
portions of a virus including at least the virus capsid. The term 
virus can refer to both viruses and phages. Entire viruses can 
include a nucleic acid genome, a capsid, and may optionally 
include an envelope. Viruses as described in the present 
invention may further include both native and heterologous 
amino acid oligomers, such as cell adhesion factors. The 
nucleic acid genome may be either a native genome or an 
engineered genome. A virus particle further includes portions 
of viruses comprising at least the capsid. 
In general, a virus particle has a native structure, wherein 
the peptide and nucleic acid portions of the virus are arranged 
in particular geometries, which are sought to be preserved 
when it is incorporated in Solid state, self Supporting forms 
such as films and fibers. 
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Viruses are preferred which have expressed peptides, 
including peptide oligomers and amino acid oligomeras spe 
cific binding sites. Amino acid oligomers can include any 
sequence of amino acids whether native to a virus or heter 
ologous. Amino acid oligomers may be any length and may 5 
include non-amino acid components. Oligomers having 
about 5 to about 100, and more particularly, about 5 to about 
30 amino acid units as specific binding site can be used. 
Non-amino acid components include, but are not limited to 
Sugars, lipids, or inorganic molecules. 
The size and dimensions of the virus particle can be such 
that the particle is anisotropic and elongated. Generally, the 
viruses may be characterized by an aspect ratio of at least 25, 
at least 50, at least 75, at least 100, or even at least 250 or 500 
(length to width, e.g., 25:1). 
A wide variety of viruses may be used to practice the 
present invention. The compositions and materials of the 
invention may comprise a plurality of viruses of a single type 
or a plurality of different types of viruses. Preferably, the 
virus particles comprising the present invention are helical 
viruses. Examples of helical viruses include, but are not lim 
ited to, tobacco mosaic virus (TMV), phage pfl. phage fall, 
CTX phage, and phage M13. These viruses are generally 
rod-shaped and may be rigid or flexible. One of skill in the art 
may select viruses depending on the intended use and prop 
erties of the virus. 
Preferably, the viruses of the present invention have been 
engineered to express one or more peptide sequences includ 
ing amino acid oligomers on the Surface of the viruses. The 
amino acid oligomers may be native to the virus or heterolo 
gous sequences derived from other organisms or engineered 
to meet specific needs. 
A number of references teach the engineering of viruses to 
express amino acid oligomers and may be used to assist in 
practicing the present invention. For example, U.S. Pat. No. 
5,403.484 by Ladner et al discloses the selection and expres 
sion of heterologous binding domains on the Surface of 
viruses. U.S. Pat. No. 5,766,905 by Studier et al discloses a 
display vector comprising DNA encoding at least a portion of 
capsid protein followed by a cloning site for insertion of a 
foreign DNA sequence. The compositions described are use 
ful in producing a virus displaying a protein or peptide of 
interest. U.S. Pat. No. 5,885,808 by Spooneretal discloses an 
adenovirus and method of modifying an adenovirus with a 
modified cell-binding moiety. U.S. Pat. No. 6,261,554 by 45 
Valerio etal shows an engineered gene delivery vehicle com 
prising a gene of interest and a viral capsid or envelope 
carrying a member of a specific binding pair. U.S. Published 
Patent Application 2001/0019820 by Li shows viruses engi 
neered to express ligands on their surfaces for the detection of 50 
molecules, such as polypeptides, cells, receptors, and channel 
proteins. 
The genetically engineered viruses can be prepared by 
methods and vectors as described in Kay, B. K. Winter, J.; 
McCafferty, J. Phage Display of Peptides and Proteins. A 55 
Laboratory Manual Academic Press: San Diego, 1996, and 
in particular, chapter 3, “Vectors for Phage Display” and 
references cited therein. In addition, the genetically engi 
neered viruses can be prepared by methods as described in, 
Phage Display, A Laboratory Manual, by Barbas et al. (2001) 60 
including Chapter 2, "Phage Display Vectors' and references 
cited therein. The type of vector is not particularly limited. 
Table 2.1 of Barbas provides exemplary vectors which can be 
used in various combinations to provide the multifunctional 
viruses. For example, type 3, type 8+8, and phagemid type 65 
p7/p9 can be combined. Or type 8 and type 3 can be combined 








can develop other combinations based on particular applica 
tions. Methods can be developed to either display the peptide 
on Some or Substantially all copies of the coat protein. 
M13 systems are a preferred example of a filamentous 
virus scaffold, but other types of filamentous virus scaffolds 
can be used as well. The wild type filamentous M13 virus is 
approximately 6.5 nm in diameter and 880 nm in length. The 
length of the cylinder reflects the length of the packaged 
single stranded DNA genome size. At one end of M13 virus, 
there are approximately five molecules each of protein VII 
(pVII) and protein IX (pDX). The other end has about five 
molecules each of protein III (plII) and protein VI (pVI), 
totaling 10-16 nm in length. The wild type M13 virus coat is 
composed of roughly 2800 copies of the major coat protein 
VIII (pVIII) stacked in units of 5 in a helical array. 
In Sum, evolution of Substrate specific peptides through 
phage display technologies for the directed nucleation of 
materials on the nanometer scale has been previously 
reported by papers and patents from Angela Belcher and 
coworkers (see above description) and serves as the basis for 
the material specificity in the virus scaffold or template (16) 
of the present invention. Screening phage libraries for the 
ability to nucleate and assemble inorganic systems including, 
for example, the ZnS, CdS (12, 17), FePt and CoPt systems 
(18) using commercially available bacteriophage libraries 
expressing either a disulphide constrained heptapeptide or a 
linear dodecapeptide, has yielded the consensus sequences 
CNNPMHQNC (termed A7; ZnS), SLTPLTTSHLRS 
(termed J140; CdS), HNKHLPSTQPLA (termed FP12: 
FePt), and ACNAGDHANC (termed CP7; CoPt). Incorpora 
tion of these peptides into the highly ordered, self assembled 
capsid of the M13 bacteriophage virus provides a linear tem 
plate which can simultaneously control particle phase and 
composition, while maintaining an ease of material adapt 
ability through genetic tuning of the basic protein building 
blocks. Because the protein sequences responsible for the 
materials growth are gene linked and contained within the 
capsid of the virus, exact genetic copies of this scaffold are 
relatively easily reproduced by infection into a large Suspen 
sion of bacterial hosts. 
To prepare nanowires, an anisotropic scaffold can be used 
which has the ability to collect nanoparticles being formed 
around it and locate them on the scaffold for fusion into a 
nanowire. In this invention, an inorganic nanowire composi 
tion can be formed having a scaffold substantially removed 
from the inorganic nanowire. Non-viral scaffolds can also be 
used including, for example, a variety of other organic scaf 
folds including, for example, scaffolds which have peptide or 
protein recognition units as side groups on an organic back 
bone. For example, the organic backbone can be a synthetic 
polymer backbone, which are well known in the art. For 
example, polymer Scaffolds can be used including for 
example modified polystyrenes of uniform molecular weight 
distribution which are functionalized with peptide units. 
Another example is branched polypeptides or nucleic acids 
which are modified to have recognition sites. Another 
example is a nanolithographically printed peptide structures 
Such as a line with nanoscale width. In general, DNA, pro 
teins, and polypeptides can be modified with recognition 
units, including peptide recognition units, to function as the 
organic scaffold. Suitable recognition units include, but are 
not limited to, amino acid oligomers, nucleic acid oligomers, 
polymers, organic molecules (e.g., antibodies, antigens, cell 
adhesion factors, and trophic factors), and inorganic materi 
als. 
In one embodiment, scaffolds and virus particles can be 
used which are not directly genetically engineered. However, 
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in general, desirable properties can be achieved when the 
virus is genetically engineered or genetic engineering is used 
in designing the scaffold. 
III. Nanowires 
Using methods described in the previous sections, viruses 
can be genetically engineered so that they function as a scaf 
fold and bind to conjugate moieties in an overall process 
which ultimately yields a production of inorganic nanowires 
according to the present invention. For example, a rod-shaped 
virus can direct the synthesis of nanoparticulates materials 
along the length of the rod, and these nanoparticulates mate 
rials can be fused into nanowires. 
In the present invention, the conjugate materials can be 
inorganic materials which form nanoparticles including inor 
ganic nanocrystals. From these inorganic nanoparticles, inor 
ganic nanowires can be formed consisting essentially of the 
fused inorganic nanoparticles upon Substantial removal of the 
scaffold. The conjugate materials and the inorganic nanow 
ires can consistessentially oftechnologically useful materials 
Such as, for example, semiconducting materials, whether 
doped or undoped; metallic materials; metal oxide materials, 
and magnetic materials. Various oxide materials including 
silica and alumina fall within the scope of the invention. 
Additional materials of interest for nanotechnology commer 
cial applications are further described in, for example: (a) 
Understanding Nanotechnology, Warner Books, 2002, 
including materials for circuits such as nanowires and nano 
tubes described in the chapter “The Incredible Shrinking Cir 
cuit. pgs. 92-103 by C. Lieber. (b) Made to Measure, New 
Materials for the 21st Century, Philip Ball, Princeton Univer 
sity, (c) Introduction to Nanotechnology, C. P. Poole Jr., F. J. 
Owens, Wiley, 2003. Preferably, for nanowires, the materials 
prepared on the scaffold conduct electricity as an electrical 
conductor, are semiconductive (whether inherently or via 
doping), transmit light, are magnetic, or possess some other 
technologically useful property. Other properties include fer 
roelectric, piezoelectric, converse-piezoelectric, and thermo 
electric). 
Semiconductors are a particularly important type of inor 
ganic nanowire material. The semiconductor material can be, 
for example, any of the standard types including alloys 
thereof including IV-IV Group (e.g., Si, Ge, III-V Group 
binary (e.g., GaN. GaP), III-V Group ternary (e.g., 
Ga(ASP)), II-VI Group binary (e.g., ZnS, ZnSe, CdS, 
CdSe, CdTe), IV-VI Group binary (e.g., PbSe), transition 
metal oxides (e.g., BiTiO), and combinations thereof. 
Magnetic materials can be those known in the art including 
nanostructured magnetic materials. See, for example, Intro 
duction to Nanotechnology, C. P. Poole Jr., F.J. Owens, Wiley, 
2003, Chapter 7, pages 165-193 (“Nanostructured Ferromag 
netism) and references cited therein (see, e.g., page 193). 
In general, although the present invention is not limited by 
theory, and the mechanism of nanowire formation is not fully 
understood, the nanowires can be structures wherein the 
nanoparticles form into nanowires and collapse into a fused 
structure at the end of the process. The porosity of the nanow 
ire is not particularly limited, but in general, non-porous 
nanowire materials are preferred, particularly for conductive 
applications wherein porosity could interfere with desired 
conductivity. 
The nanowire can be crystalline. The nanowire can be a 
single crystalline domain or can have one or more crystalline 
domains. In one embodiment, the fused nanoparticles are 
single crystalline. The crystalline phase can be either the 
thermodynamically favorable crystalline state or a crystalline 
state which is not thermodynamically favorable but is locked 













before fusion. The nanoparticles can be oriented in any man 
ner. For example, the crystallographic axis of the nanopar 
ticles can be oriented with respect to the surface of the scaf 
fold. One can vary the thermal treatment in the method of 
making (see below) to achieve a desired crystalline structure, 
or to covert polycrystalline structures to single crystalline 
structures. One can also vary the thermal treatment to remove 
the organic scaffold. In some cases fusion and organic scaf 
fold removal are achieved at the same temperature, in other 
cases, fusion can occur before removal. 
The length of the nanowire can be, for example, about 250 
nm to about 5 microns, or more particularly, about 400 nm to 
about 1 micron. 
The width of the nanowire can be, for example, about 5 nm 
to about 50 nm, or more particularly, about 10 nm to about 30 
. 
In some embodiments, the length of the nanowire can be, 
for example, about 250 nm to about 5 microns, and have a 
width, for example, of about 5 nm to about 50 nm. In other 
embodiments, the length of the nanowire can be, for example, 
about 5 nm to about 50 nm, and have a width, for example, of 
about 10 nm to about 30 nm. 
When a plurality of nanowires is present, the lengths and 
widths can be expressed as average lengths and widths using 
known statistical methods in materials Science. For example, 
the average length of the nanowire can be, for example, about 
250 nm to about 5 microns, or more particularly, about 400 
nm to about 1 micron. The average width of the nanowire can 
be, for example, about 5 nm to about 50 nm, or more particu 
larly, about 10 nm to about 30 nm. 
Also, when a plurality of nanowires is present, the nanow 
ires can be substantially monodisperse in length and/or width. 
The monodispersity can be accomplished, because the 
nanowires are assembled from scaffolds with uniform length 
and width. Again, known statistical methods in material sci 
ence can be used to calculate the polydispersity for length and 
width. For example, images of the nanowires can be obtained 
and, for example, 20-50 nanowires can be selected for statis 
tical analysis. The coefficient of variation (CV) can be calcu 
lated wherein the standard deviation is divided by the mean. 
The CV can be, for example, less than about 20%, more 
preferably, less than about 10%, more preferably, less than 
about 5%, and more preferably, less than about 3%. 
The nanowires can be substantially straight. For example, 
straightness can be estimated by (1) measuring the true length 
of the nanowire, (2) measuring the actual end to end length, 
(3) calculate the ratio of true length to actual end to end 
length. For a perfectly straight nanowire, this ratio will be 
one. In the invention, ratios close to one can be achieved 
including, for example, less than 1.5, less than 1.2, and less 
than 1.1. 
The inorganic nanowires of the present invention can also 
beformed in combination with other types of conjugate mate 
rials to form larger structures using, for example, multifunc 
tional scaffolds. Hence, the conjugate material is not particu 
larly limited to inorganic materials for these larger structures 
and combinations of materials can be used. In general, it will 
be selected for a particular application. It can be selected So 
that the virus particles can be subjected to biopanning against 
the conjugate material, and then the conjugate material is 
selectively or specifically bound to the virus particle. In some 
applications, selective binding can be sufficient, whereas in 
other applications, a more powerful specific binding can be 
preferred. Examples of general types of conjugate materials 
which can be used in larger structures include inorganic, 
organic, particulate, nanoparticulate, single crystalline, poly 
crystalline, amorphous, metallic, magnetic, semiconductor, 
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polymeric, electronically conducting, optically active, con 
ducting polymeric, light-emitting, and fluorescent materials. 
Conjugate materials are described further, for example, in the 
patent publications and technical literature to Angela Belcher 
and co-workers cited throughout this specification. 
In Sum, the present invention relates to the general, univer 
sal synthesis of 1-D nanostructures, including nanowires, 
based on, in preferred embodiments, a genetically modified 
virus scaffold for the directed growth and assembly of crys 
talline nanoparticles into 1-D arrays, followed by annealing 
of the virus-particle assemblies into high aspect ratio, crys 
talline nanowires through oriented, aggregation-based crystal 
growth (14, 15) (FIG. 2A). The synthesis of analogous 
nanowire structures from fundamentally different materials, 
e.g., the II-VI semiconductors ZnS and CdS and the L1 
ferromagnetic alloys CoPt and FePt, demonstrates both the 
generality of the virus scaffold and the ability to precisely 
control material characteristics through genetic modification. 
In contrast to other synthetic methods (6), this approach 
allows for the genetic control of crystalline semiconducting, 
metallic, oxide, and magnetic materials with a universal scaf 
fold template. 
IV. Method of Making Inorganic Nanowires 
The present invention also provides methods of making the 
inorganic nanowires, which are further exemplified in the 
below working examples. For example, the invention pro 
vides a method of forming an inorganic nanowire comprising 
the steps of: (1) providing one or more precursor materials for 
the inorganic nanowire; (2) providing an elongated organic 
scaffold; (3) reacting the one or more precursor materials in 
the presence of the scaffold to form nanoparticles, wherein 
the nanoparticles are disposed along the length of the elon 
gated organic scaffold; and (4) thermally treating the scaffold 
and the nanoparticles to form the inorganic nanowire by 
fusion of the nanoparticles. In some embodiments, the ther 
maltreatment is not performed, and the method comprises the 
steps listed as (1)–(3) above. This method of forming a nanow 
ire can also be used to form a plurality of nanowires. 
In these methods, the inorganic nanowires are described in 
the previous section including the crystallinity, types of mate 
rials, size including length and width, monodispersity, and 
straightness. Also, in these methods, the elongated organic 
scaffold is described above including the viral system with its 
potential for selective recognition. These methods include 
situations involving the Substantial removal of the organic 
scaffold. 
The invention is not particularly limited by the type of 
reaction and the precursor materials used to form the nanow 
ire. In general, the reaction and the precursor materials should 
be compatible with the scaffold. Reactions attemperatures of 
below 100° C. can be used to form the nanoparticles. In a 
preferred embodiment, the treating step comprises a chemical 
reduction of metal precursor salts. Precursor material can be 
preformed nanoparticles or materials that form nanoparticles, 
for example. 
In a preferred embodiment, the nanoparticles can have an 
average diameter of about 2 nm to about 10 nm, and more 
particularly, about 3 nm to about 5 nm. The nanoparticles can 
be crystalline before and/or after the thermal treating. The 
nanoparticles can be fused before and/or after thermal treat 
ment. For example, the thermal treatment may act to fuse the 
nanoparticles, which were not fused prior to the thermal 
treatment. The nanoparticles can be oriented or not oriented. 
The temperature and time of the thermal treatment step are 
not particularly limited but can vary depending on the pre 
cursor materials used and the material of the final nanowire. 













ior of the materials can be considered in selecting tempera 
ture. In general, temperatures of about 100° C. to about 
1,000° C. can be used. Thermal treatment can be used to fuse 
the nanoparticles into a single structure and also to remove the 
scaffold, tailored for a particular application with particular 
materials. In principle, the porosity of the nanowire and the 
degree of fusion of the nanoparticles can be affected by the 
temperature. In a preferred embodiment, the thermal treat 
ment step can be carried out at about 300° C. or higher, up to 
about 500° C. In general, and depending on the materials, 
lower temperatures can be used such as, for example, about 
200° C. to about 300° C. if more porous nanowires are desired 
with less fusion. The thermal treatment step can be carried out 
at a temperature below the melting temperature of the precur 
sor material. The temperature can be selected to achieve a 
desired crystalline phase which may be a low energy phase or 
a high energy phase. If desired, a temperature programming 
step can be used to tailor the fusion of the nanoparticles, the 
targeted crystal phase, and the removal of the scaffold, if 
desired. Higher temperatures of, for example, about 500° C. 
to about 1,000° C. can be used to ensure the scaffold is 
completely removed and burned off. Lower temperatures, for 
example, about 50° C. to 300° C. can be used to avoid 
removing the scaffold. However, temperature and time can be 
selected so as to not result in excessive oxidation of the 
nanowires. The time of the thermal treatment is not particu 
larly limited but can be, for example, 30 minutes to 12 hours. 
Preferably, the temperature and time for thermal treatment 
can be adjusted to achieve the optimum balance for nanopar 
ticle fusion while reducing oxide formation and improving 
the stability of the crystal structure. 
In one embodiment, the invention provides a process for 
producing nanowires with use of an elongated organic scaf 
fold comprising the steps of: (1) providing an elongated 
organic scaffold which comprises a plurality of binding sites 
including binding sites along the length of the scaffold and 
binding sites on at least one end of the scaffold; (2) disposing 
a nanowire precursor composition along the length of the 
scaffold to form a scaffolded precursor composition; and (3) 
treating the scaffolded precursor composition to form the 
nanowire. In one embodiment, the elongated organic scaffold 
has binding sites at both ends of the scaffold. In another 
embodiment, the process further comprises the step of using 
the binding site at the end of the scaffold to bind to another 
structure. The other structure can be, for example, another 
elongated organic scaffold. an electrode, a circuit element, a 
semiconductor material, an electrically conductive material, 
a magnetic material, or a biological molecule. The scaffold 
can be bound to a patterned structure, Such as a circuit Sub 
strate. The treating step may be a thermal treatment step as 
described in detail herein. The scaffold can be removed or left 
intact. 
V. Applications 
The nanowires of the present invention can be used in many 
different commercial applications, some of which are noted 
above, including the cited patent applications, and in the cited 
references at the end of the specification. The nanowires can 
be used, for example, in applications requiring electrical con 
ductivity or semiconductivity at the nanoscale. The large 
Surface area to Volume ratio of nanowires is advantageous for 
applications, such as, fule cells, thin film batteries, and Super 
capacitors. In some applications, a single nanowire can be 
used. In other applications, a plurality of nanowires can be 
used, whether in a parallel or crossed manner. In general, 
organized arrangements of nanowires are advantageous. In 
Some applications, the nanowire can be surface modified, 
doped, or otherwise modified in its material structure for the 
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application. Modifications include both chemical and bio 
logical modifications. Microcircuitry, nanocircuitry, macro 
electronics, photovoltaics, Solar cells, chemical and biologi 
cal sensors, optical components, field emitting tips and 
devices, nanocomputing, nanoSwitches, molecular wire 
crossbars, batteries, fuel cells, catalysts, very large flat panel 
displays, tiny radio frequency identification devices, Smart 
cards, phased array RF antennas, disposable computing and 
storage electronics, nanoscale bar codes, crossbar nanostruc 
tures, biosensor arrays, high density data storage, field effect 
transistors, and the like are representative examples of appli 
cations for the nanowires. Particularly important semicon 
ductive elements include, for example, p-n diodes, p-i-n 
diodes, LEDs, and bipolar transistors. Nanowires can be 
incorporated into a number of devices, such as electronic, 
optoelectronic, electrochemical, and electromechanical 
devices. A single nanowire can connect elements in a device 
or a series of connected segments of nanowires can connect 
elements. For example, a field effect transistor device may 
comprise nanowires in both a parallel and crossed arrange 
ment. 
Applications of nanowires are described in, for example, 
U.S. patent application publication no. 2003/0089899 (pub 
lished May 15, 2003) to Lieberetal. and include, for example, 
field effect transistors, sensors, and logic gates, and this pub 
lication is hereby incorporated by reference in its entirety 
including its description of devices made from nanowires. 
Additional applications of nanowires are described in, for 
example, U.S. patent application publication no. 2003/ 
0200521 (published Oct. 23, 2003) to Lieberetal. and include 
nanoscale crosspoints, which is incorporated by reference in 
its entirety. Additional applications of nanowires are 
described in, for example, U.S. patent application publication 
no. 2002/0130353 (published Sep. 19, 2002) to Lieber et al. 
and include devices with chemical patterning and bistable 
devices. Additional applications of nanowires are described 
in, for example, U.S. patent application publication no. 2002/ 
01 17659 (published Aug. 29, 2002) to Lieber et al. and 
include nanosensors for chemical and biological detection. In 
addition, applications for related nanorods are described in, 
for example, U.S. Pat. Nos. 6,190,634; 6,159,742: 6,036,774; 
5,997,832; and 5,897,945 to Lieber et al. A number of litera 
ture references teach applications of nanowires and related 
technology, such as Choi et al., J. Power Sources 124:420 
(2003); Cuiet al., Science 293:1289-1292 (2001); De Heeret 
al., Science 270: 1179-1180 (1995); and Dominko et al., 
Advanced Materials 14(21): 1531-1534 (2002), which all of 
which are herein incorporated by reference in their entirety. 
Of particular importance for this invention, the scaffold can 
be used to direct the nanowire to other structures so the 
scaffold is an active scaffold rather than a passive scaffold. 
For example, viruses can be conjugated with one-dimen 
sional nanowires/nanotubes, two dimensional nano elec 
trodes, and microscale bulk devices. One-dimensional mate 
rials, such as nanotubes or nanowires, when conjugated with 
the pII end of M13 viruses, may form phase separated lamel 
lar structures that have inorganic nanotube or nanowire layers 
and phage building block layers. Two-dimensional nano 
thick plate shaped electrodes can be organized. Viral-semi 
conductor composite nanowires can be attached across metal 
electrodes, including noble metal electrodes such as gold 
electrodes, through binding sites at either end of the virus. 
The nanowire can bridge a source and a drain. The nanowire 
precursor can be disposed on or adjacent to the electrodes and 
then the scaffold can be removed so that the nanowire can be 
intimately in electrical contact with the electrode in a final 














ing the electrodes with the nanowire or after bridging the 
nanowire to the electrodes, as long as the nanowire ultimately 
functions as a bridge. These structures can function as nano 
FET devices with enhanced performance due to the c.a. 5 nm. 
diameter of the gate region. Unlike other proposed nano-scale 
devices, where wire placement must be done stochastically, 
this approach directs single wires to the correct electrode 
locations. Alternative cathode and anode structures might be 
useful for nanosize biofuel cells. When the specific binding 
M13 virus combined with micro-size objects, periodic orga 
nization of these micro-dimensional objects is also possible. 
The role of the M13 virus will be the specific adhesive unit to 
self-assemble multiple different objects in periodic patterns. 
The engineering ability of the M13's various proteins can be 
a key factor in the development of these viral-inorganic 
hybrid-based arrays. In addition, fibers or fabric like networks 
of viruses can be constructed with specifically designed 
mechanical properties based on the secondary and tertiary 
structures induced by viral-viral binding. In addition these 
materials can have special properties impregnated into them 
by further functionalizing the viruses to bind regents or sig 
naling elements. 
Additionally, multifunctional viral based arrays can have 
uses in tissue repair where one part of the array selectively 
binds to a tissue type where another part can nucleate bone or 
other structural bio-materials. Additionally, catalytic nano 
structures can be developed by controlling elemental identity 
and geometrical arrangement of molecular catalytic moieties. 
The exploitation of the self-assembly motifs employed by 
the M13 bacteriophage to produce a biological scaffold pro 
vides methods of generating a complex, highly ordered, and 
economical template for the general synthesis of single crys 
tal nanowires. By introducing programmable genetic control 
over the composition, phase and assembly of nanoparticles, a 
generic template for the universal synthesis of a variety of 
materials can be realized. Further advances in the fabrication 
of nanoscale materials and devices can be achieved through 
modification of the remaining four proteins in the virus to 
incorporate device-assembly directors. The ability of viruses 
to form liquid crystal and otherwise aligned and ordered 
systems, based on their shape anisotropy, is another promis 
ing route for the assembly of virus-based nanowires into well 
ordered arrays on multiple length scales (11). Overall, modi 
fication of biological systems by the introduction of substrate 
specific peptides presents a method of achieving well ordered 
nanomaterials in a cost-effective and Scalable manner. 
In particular, when amino acid oligomers are expressed on 
a Surface, the expression of the amino acid oligomers may 
serve a number of commercially useful functions, including 
but not limited to, cell adhesion factors, trophic factors, or 
binding sites for organic or inorganic molecules. Expression 
of amino acid oligomers allows the viruses to be engineered 
to specific applications. For example, the films or fibers com 
prising engineered fibers may contain amino acid oligomers 
that initiate or enhance cell growth for use in tissue engineer 
ing applications. In another example, amino acid oligomers 
with specificity for a specific inorganic molecule may be 
expressed to bind the inorganic molecule to increase the effi 
ciency of a chemical reaction. In still another example, the 
expressed amino acid oligomer may bind an organic mol 
ecule, such as a biodefense agent. Such films or fibers could 
be incorporated into the clothing of military personnel or first 
responders as part of a sensor System. 
These are only a few examples of the utility of films and 
fibers made from engineered viruses, and other applications 
are readily apparent to one of skill in the art. 
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WORKING EXAMPLES 
The present invention is further characterized by the fol 
lowing non-limiting working examples including FIGS. 2 
and 3 and description and discussion thereof. One skilled in 5 
the art can use as guidance FIGS. 1-3 in the practice of the 
present invention which provide an introduction to the work 
ing examples. 
FIG. 1 
FIG. 1A illustrates the nanowire synthesis scheme or the 
nucleation, ordering and annealing of virus-particle assem 
blies. FIG. 1B shows the symmetry of the virus. The symme 
try allows for ordering of the nucleated particles along the X, 
y, and Z directions fulfilling requirements for aggregation 
based annealing. FIG. 1C shows the highly ordered nature of 15 
the M13 bacteriophage. The highly ordered nature of the self 
assembled M13 bacteriophage promotes the preferred orien 
tation seen in nucleated particles through the rigidity and 
packing of the expressed peptides, which is visualized at 20% 
incorporation. FIG. 1D shows the construct of the M13 bac- 20 
teriophage virus. The construct has genetically modifiable 
capsid and ends, specifically the gPVIII, gPIII, and gPIX, 
which are coded for in the phagemid DNA enclosed within 
the virus capsid. 
FIG 2 
FIGS. 2A-F shows electron microscopy of both the pre 
and post-annealed ZnS and CdS viral nanowires. FIG. 2A 
shows Dark-field Diffraction-contrast imaging of the pre 
annealed ZnS system using the (100) reflection reveals the 
crystallographic ordering of the nucleated nanocrystals, 30 
where contrast stems from satisfying the (100) Bragg diffrac 
tion condition. The inset of FIG. 2A shows the ED pattern of 
the polycrystalline pre-annealed wire showing the Wurtzite 
crystal structure and the single crystal type 001 Zone axis 
pattern, Suggesting a strong Zone axis preferred orientation of 35 
the nanocrystals on the viral template. The electron diffrac 
tion (ED) pattern (inset of FIG. 2A) shows single crystal-type 
behavior, even though the sample area is composed of many 
nanocrystals. This behavior Suggests that the nanocrystals on 
the virus were preferentially oriented with their c-axes per 
pendicular to the viral surface. FIG. 2B is a Bright-field TEM 
image of an individual ZnS single crystal nanowire formed 
after annealing. The upper left inset of FIG. 2B shows the ED 
pattern along the 001 Zone axis shows a single crystal wurtz 
ite structure of the annealed ZnS nanowire. The lower right 
inset of FIG. 2B is a low magnification TEM image showing 
the monodisperse, isolated single crystal nanowires. FIG. 2C 
shows a typical HRTEM of a ZnS single crystal nanowire 
showing a lattice image that continually extends the length of 
the wire, confirming the single crystal nature of the annealed 
nanowire. The measured lattice spacing of 0.33 nm corre 
sponds to the (010) planes in wurtzite ZnS crystals. A 30° 
orientation of (010) lattice planes with respect to the nanowire 
axis is consistent with the (100) growth direction determined 
by ED. FIG. 2D HAADF-STEM image of single crystal ZnS 
nanowires, which were annealed on a silicon wafer. FIG. 2E 
shows HAADF STEM images of CdS single crystal nanow 
ires. FIG. 2F is an HRTEM lattice image of an individual CdS 
nanowire. The experimental lattice fringe spacing, 0.24 nm, is 
consistent with the unique 0.24519 nm separation between 
two (102) planes in bulk wurtzite CdS crystals. 
FIG.3 
FIG. 3A shows CoPt wires as synthesized by the modified 
virus template where soluble in water. Reduction of Co and Pt 
salts without the presence of the virus yielded large precipi 
tates which immediately fell out of solution. FIG. 3B shows a 










3B shows a STEM image of unannealed CoPt wires. The 
scale bar shown is 100 nm. FIG: 3C shows a low resolution 
TEM image of crystalline L1 CoPt wires (about 650 
nmxabout 20 nm). The tendency of the CoPt and FePt wires 
to not be straight may stem from magnetic interactions 
between wires and/or nanoparticles not present in the II-VI 
systems. The inset of FIG. 3C is an ED showing the charac 
teristic (110) and (001), L10 lines, and the crystallinity of the 
system. FIG. 3D is an HRTEM of the CoPt wires with the 
(111) plane perpendicular to the c-axis of the wire. The inset 
ED reveals the superlattice structure unique to the L10 phase. 
FIG.3E is a TEM imaging of the unannealed FePt wires. FIG. 
3F shows a TEM of the annealed FePt wires. The inset ED 
pattern confirms the L10 nature of the FePt wires and shows 
the crystalline nature of the material. 
Engineering M13 Bacteriophage 
The M13 bacteriophage used in the working examples is a 
high production rate virus (200 mg/L) comprised of five 
genetically modifiable proteins (19, 20, 21); gene products 
(gP)-3, 6, 7, 8 and 9, of which ~2700 copies of the gP8 protein 
forms the capsid of the wild type virus. The gP8 protein was 
genetically modified and expressed using a phagemid system, 
resulting in fusion of the Substrate specific peptides to the 
N-terminus of the gP8 protein (12). During assembly, stack 
ing of the gP8 unit cell results in a five-fold symmetry down 
the length (c-axis) of the virus and is the origin of the ordering 
offusion peptides in a three-dimensional structure (FIG. 1B). 
Computational analysis of peptide expression on the capsid 
of the virus revealed that the nearest neighbor peptide sepa 
ration stabilized around 3 nm at and above 20% incorporation 
(FIG. 1C). Consequently, high incorporation of the substrate 
specific fusion peptides is not required for complete miner 
alization of the virus to occur. Tri-functional templates can be 
realized through further genetic modification of the proximal 
and remote tips of the virus (specifically the gP3 and gP9 
proteins, 22) which can be used to push the current system to 
higher aspect ratios and introduce materials including mate 
rials such as, for example, noble metals, semiconductors, and 
oxides to assemble functional heterostructured materials 
(FIG. 1D). 
Mineralization of Scaffolds 
Mineralization of the ZnS and CdS systems have been 
described previously (11, 12, 17) and involves incubation of 
the viral template with metal salt precursors at reduced tem 
peratures to promote uniform orientation of the nanocrystals 
during nucleation (23), leading to the preferred crystallo 
graphic orientation of nucleated nanocrystals with respect to 
the long axis of the virus. Prior to annealing, wurtzite ZnS and 
CdS nanocrystals (3-5mm) grown on the virus surface were in 
close contact and preferentially oriented with the 001 direc 
tion and the (100) plane perpendicular to the wire length 
direction, which is supported by Electron Diffraction (ED), 
High Resolution Transmission Electron Microscopy (HR 
TEM), High Angle Annular Dark Field Scanning Transmis 
sion Electron Microscopy (HAADF-STEM), and Dark-field 
Diffraction-contrast Imaging (FIG. 2) (24). Particles attached 
to the virus were likely prohibited from fusing under initial 
synthesis conditions likely due for example to the blocking 
effects of the neighboring peptides, and therefore removal of 
the template was desired in order to form single crystal 
nanowires. Thermal analysis of the virus-particle system 
showed complete removal of the organic materials by 350° C. 
(25), which corresponded to the minimum temperature 
observed for the fusion of adjacent particles by TEM with 
annealing performed in situ using a thermal stage (26). 
US 8,523,044 B2 
19 
Formation of Nanowires 
Annealing of the mineralized viruses at temperatures 
below the ZnS and CdS particle melting point (400-500° C.) 
allowed the polycrystalline assemblies to form single crystal 
nanowires (for ZnS nanowires, length distribution was about 
600-650 nmi; for CdS nanowires, length distribution was 
about 475-500 nm, the diameters for ZnS and CdS nanowires 
were about 20 nm) through removal of the organic template 
and minimization of the interfacial energy (27) (FIG. 2B, E). 
ED and HRTEM revealed the single crystal nature of indi 
vidual nanowires that inherited the preferred orientation seen 
in the precursor polycrystalline wires through removal of the 
grainboundaries (28, 29) (FIGS. 2C and D). The 100 direc 
tion and (001) plane orientations of the observed ZnS nanow 
ires where consistent with common elongation directions for 
II-VI nanowires, even though these are thermodynamically 
high energy planes (FIGS. 2B and C: 14, 30, 31). HRTEM of 
the single crystal CdS nanowires revealed a lattice spacing of 
2.4A that was consistent with the unique 2.4519 A separation 
between two (102) planes in bulk wurtzite CdS crystals 
(JCPDS #41-1049). The 43.1° orientation of (102) lattice 
planes with respect to the nanowire axis indicated that the 
nanowire was elongated along the 001 direction and again 
confirmed the wurtzite structure (FIG. 2F). 
Formation of Ferromagnetic Nanowires 
Extending the virus-directed synthesis approach to the fer 
romagnetic L1 CoPt and FePt systems was carried out for 
demonstrating both the diversity of applicable materials and 
to address current technological issues regarding the devel 
opment of low-dimensional magnetic materials. Platinum 
alloyed magnetic materials of the chemically ordered Llo 
phase have been of recent interest due to their high coercivity, 
resistance to oxidation, and inherent magnetic anisotropy 
important for ultrahigh density recording media (32). 
Although synthetic routes such as VLS yield exquisite 1-D 
semiconducting structures and non-specific template 
schemes are applicable to a range of materials, both have 
faced difficulties in producing high-quality, crystalline metal 
lic and magnetic nanowires in free standing form (33). 
Genetically Engineered Scaffolds 
The M13 bacteriophage was modified by fusing either the 
CP7CoPt specific or FP12 FePt specific peptide into the virus 
capsid. Nucleation of the CoPt and FePt particles was 
achieved via the chemical reduction of metal precursor salts 
in the presence of gP8 modified viruses (18.34). Annealing of 
the assemblies at 350° C. promoted the growth of crystalline 
CoPt and FePt nanowires of the L1 phase that were uniform 
in diameter (10 nm +/-5%). The crystalline nature of the 
wires can be seen in the selected area ED pattern, which also 
shows the characteristic (001) and (110) L1 peaks, and by 
high resolution TEM lattice imaging (FIG. 3C, D). The (111) 
plane perpendicular to the long axis of the CoPt wires with a 
lattice spacing of 2.177A was in agreement with the reported 
value of 2.176 A, and again confirmed the highly crystalline 
nature of the material (FIG. 3D, JCPDS #43-1358). The per 
sistence of the L1 phase, which is kinetically accessible 
above 550° C. (15), was attributed to the propensity of par 
ticles to maintain their orientation during aggregation-based 
annealing. 
Nanowire Design Simulations 
The invention including the working examples can be fur 
ther understood with use of simulation methods. For example, 
Monte Carlo simulations of the A7 constrained sequence 
resulted in a 21% decrease in the standard deviation of back 
bone dihedral angles upon transfer of the peptide from isola 
tion into the capsid environment, demonstrating the rigidity 













particles with regards to preferred crystallographic orienta 
tion along the length of the virus was believed to be a result of 
the stability of the peptide fusion and the symmetry of the 
virus coat. This nanocrystal ordering promoted the single 
crystal nature of the annealed nanowires by satisfying the 
orientation requirements of the aggregation-based crystal 
growth mechanism (14). Although particles exhibiting orien 
tations not coherent with that of the majority were to be 
expected, these minority nanocrystals should rotate to adopt 
the preferred crystallographic orientation and merge with the 
majority to minimize both the interfacial and grain boundary 
energies (31, 36,37). 
Additional experimental details can be found in several of 
the below footnotes. 
Although making and using various embodiments of the 
present invention are discussed in herein, it will be appreci 
ated that the present invention provides many applicable 
inventive concepts that can be embodied in a wide variety of 
specific contexts. The specific embodiments discussed herein 
are merely illustrative of specific ways to make and use the 
invention, and do not delimit the scope of the invention. 
The following references are not admitted prior art but can 
be used to guide one skilled in the art in the practice of the 
present invention, and also are incorporated herein by refer 
ence in their entirety. 
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The invention claimed is: 
1. A method of forming an inorganic nanowire, compris 
1ng: 
providing an elongated organic scaffold; 
providing a plurality of inorganic nanoparticles attached to 
the organic scaffold along a length of the organic scaf 
fold; and 
fusing the nanoparticles attached to the organic scaffold to 
form an inorganic nanowire. 
2. The method of claim 1, wherein the organic scaffold 
comprises a plurality of binding sites along the length of the 
organic scaffold for binding the inorganic nanoparticles. 
3. The method of claim 2, wherein the elongated organic 
scaffold comprises peptides along the length of the organic 
scaffold which bind the nanoparticles. 
4. The method of claim 3, wherein the elongated organic 
scaffold comprises a virus. 
5. The method of claim 1, wherein the fusing step com 
prises heating the nanoparticles to between about 100° C. and 
1OOOO C. 
6. The method of claim 1, further comprising the step of 
removing the elongated organic scaffold from the fused nano 
particles. 
7. The method of claim 1, wherein the elongated organic 
scaffold comprises binding sites at at least one end of the 






8. The method of claim 7, wherein the binding sites at at 
least one end of the elongated organic scaffold are configured 
to bind to another elongated organic scaffold. 
9. The method of claim 1, wherein the nanoparticles 
attached to the elongated organic scaffold comprise the same 
composition. 
10. The method of claim 1, wherein the nanoparticles 
attached to the elongated organic scaffold comprise different 
compositions. 
11. The method of claim 10, wherein the nanoparticles of 
different composition are arranged along the length of the 
elongated organic scaffold in a periodic pattern. 
12. The method of claim 1, wherein the nanoparticles com 
prise a semiconductor material, a metallic material, a metal 
oxide material, a magnetic material, or mixtures thereof. 
13. The method of claim 1, comprising providing a plural 
ity of elongated organic scaffolds having a plurality of inor 
ganic nanoparticles attached along a length thereof, and fus 
ing the nanoparticles to form a plurality of inorganic 
nanowires. 
14. The method of claim 1, wherein the formed nanowire 
has a length of from about 250 nm to about 5 microns and a 
width of from about 5 nm to about 50 nm. 
15. The method of claim 13, wherein the plurality of 
nanowires formed comprises a Substantially monodisperse 
average length. 
16. The method of claim 13, wherein the plurality of 
nanowires formed comprises a Substantially monodisperse 
average width. 
